English
简体中文
Total: £ 56.28
Published Date: 2026-03-24 | Pages: 113 | Tables: 113 | Pharma & Healthcare
The global Anti-SCD1 Antibody market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Anti-SCD1 Antibody competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Anti-SCD1 antibody is a kind of antibody that specifically targets and binds to Stearoyl-CoA desaturase 1 (SCD1), a key enzyme involved in lipid metabolism, typically used in research settings to study the role of SCD1 in various biological processes.
The North American market for Anti-SCD1 Antibody is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Anti-SCD1 Antibody is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Anti-SCD1 Antibody include Abcam, Bioss, Bethyl Laboratories, HUABIO, Biorbyt, Santa Cruz Biotechnology, LSBio, OriGene Technologies, Thermo Fisher Scientific, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Anti-SCD1 Antibody market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Anti-SCD1 Antibody. The Anti-SCD1 Antibody market size, estimates, and forecasts are provided in terms of sales volume (kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Anti-SCD1 Antibody market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Anti-SCD1 Antibody manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Abcam
Bioss
Bethyl Laboratories
HUABIO
Biorbyt
Santa Cruz Biotechnology
LSBio
OriGene Technologies
Thermo Fisher Scientific
Segment by Type
Monoclonal Anti-SCD1 Antibody
Polyclonal Anti-SCD1 Antibody
by Application
Co-Immunoprecipitation
Western Blot
Immunofluorescence
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Anti-SCD1 Antibody manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Anti-SCD1 Antibody sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Anti-SCD1 Antibody Market Overview
1.1 Product Definition
1.2 Anti-SCD1 Antibody by Type
1.2.1 Global Anti-SCD1 Antibody Market Value by Type: 2025 vs 2032
1.2.2 Monoclonal Anti-SCD1 Antibody
1.2.3 Polyclonal Anti-SCD1 Antibody
1.3 Anti-SCD1 Antibody by Application
1.3.1 Global Anti-SCD1 Antibody Market Value by Application: 2025 vs 2032
1.3.2 Co-Immunoprecipitation
1.3.3 Western Blot
1.3.4 Immunofluorescence
1.3.5 Others
1.4 Global Anti-SCD1 Antibody Market Size Estimates and Forecasts
1.4.1 Global Anti-SCD1 Antibody Revenue 2021–2032
1.4.2 Global Anti-SCD1 Antibody Sales 2021–2032
1.4.3 Global Anti-SCD1 Antibody Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Anti-SCD1 Antibody Market Competition by Manufacturers
2.1 Global Anti-SCD1 Antibody Sales Market Share by Manufacturers (2021–2026)
2.2 Global Anti-SCD1 Antibody Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Anti-SCD1 Antibody Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Anti-SCD1 Antibody, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Anti-SCD1 Antibody, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Anti-SCD1 Antibody, Product Types and Applications
2.7 Global Key Manufacturers of Anti-SCD1 Antibody, Date of Entry into the Industry
2.8 Global Anti-SCD1 Antibody Market Competitive Situation and Trends
2.8.1 Global Anti-SCD1 Antibody Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Anti-SCD1 Antibody Players Market Share by Revenue
2.8.3 Global Anti-SCD1 Antibody Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti-SCD1 Antibody Market Scenario by Region
3.1 Global Anti-SCD1 Antibody Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Anti-SCD1 Antibody Sales by Region: 2021–2032
3.2.1 Global Anti-SCD1 Antibody Sales by Region: 2021–2026
3.2.2 Global Anti-SCD1 Antibody Sales by Region: 2027–2032
3.3 Global Anti-SCD1 Antibody Revenue by Region: 2021–2032
3.3.1 Global Anti-SCD1 Antibody Revenue by Region: 2021–2026
3.3.2 Global Anti-SCD1 Antibody Revenue by Region: 2027–2032
3.4 North America Anti-SCD1 Antibody Market Facts & Figures by Country
3.4.1 North America Anti-SCD1 Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Anti-SCD1 Antibody Sales by Country (2021–2032)
3.4.3 North America Anti-SCD1 Antibody Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-SCD1 Antibody Market Facts & Figures by Country
3.5.1 Europe Anti-SCD1 Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Anti-SCD1 Antibody Sales by Country (2021–2032)
3.5.3 Europe Anti-SCD1 Antibody Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-SCD1 Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific Anti-SCD1 Antibody Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Anti-SCD1 Antibody Sales by Region (2021–2032)
3.6.3 Asia Pacific Anti-SCD1 Antibody Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Anti-SCD1 Antibody Market Facts & Figures by Country
3.7.1 Latin America Anti-SCD1 Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Anti-SCD1 Antibody Sales by Country (2021–2032)
3.7.3 Latin America Anti-SCD1 Antibody Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Anti-SCD1 Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-SCD1 Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Anti-SCD1 Antibody Sales by Country (2021–2032)
3.8.3 Middle East and Africa Anti-SCD1 Antibody Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-SCD1 Antibody Sales by Type (2021–2032)
4.1.1 Global Anti-SCD1 Antibody Sales by Type (2021–2026)
4.1.2 Global Anti-SCD1 Antibody Sales by Type (2027–2032)
4.1.3 Global Anti-SCD1 Antibody Sales Market Share by Type (2021–2032)
4.2 Global Anti-SCD1 Antibody Revenue by Type (2021–2032)
4.2.1 Global Anti-SCD1 Antibody Revenue by Type (2021–2026)
4.2.2 Global Anti-SCD1 Antibody Revenue by Type (2027–2032)
4.2.3 Global Anti-SCD1 Antibody Revenue Market Share by Type (2021–2032)
4.3 Global Anti-SCD1 Antibody Price by Type (2021–2032)
5 Segment by Application
5.1 Global Anti-SCD1 Antibody Sales by Application (2021–2032)
5.1.1 Global Anti-SCD1 Antibody Sales by Application (2021–2026)
5.1.2 Global Anti-SCD1 Antibody Sales by Application (2027–2032)
5.1.3 Global Anti-SCD1 Antibody Sales Market Share by Application (2021–2032)
5.2 Global Anti-SCD1 Antibody Revenue by Application (2021–2032)
5.2.1 Global Anti-SCD1 Antibody Revenue by Application (2021–2026)
5.2.2 Global Anti-SCD1 Antibody Revenue by Application (2027–2032)
5.2.3 Global Anti-SCD1 Antibody Revenue Market Share by Application (2021–2032)
5.3 Global Anti-SCD1 Antibody Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Abcam
6.1.1 Abcam Company Information
6.1.2 Abcam Description and Business Overview
6.1.3 Abcam Anti-SCD1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Abcam Anti-SCD1 Antibody Product Portfolio
6.1.5 Abcam Recent Developments/Updates
6.2 Bioss
6.2.1 Bioss Company Information
6.2.2 Bioss Description and Business Overview
6.2.3 Bioss Anti-SCD1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Bioss Anti-SCD1 Antibody Product Portfolio
6.2.5 Bioss Recent Developments/Updates
6.3 Bethyl Laboratories
6.3.1 Bethyl Laboratories Company Information
6.3.2 Bethyl Laboratories Description and Business Overview
6.3.3 Bethyl Laboratories Anti-SCD1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Bethyl Laboratories Anti-SCD1 Antibody Product Portfolio
6.3.5 Bethyl Laboratories Recent Developments/Updates
6.4 HUABIO
6.4.1 HUABIO Company Information
6.4.2 HUABIO Description and Business Overview
6.4.3 HUABIO Anti-SCD1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 HUABIO Anti-SCD1 Antibody Product Portfolio
6.4.5 HUABIO Recent Developments/Updates
6.5 Biorbyt
6.5.1 Biorbyt Company Information
6.5.2 Biorbyt Description and Business Overview
6.5.3 Biorbyt Anti-SCD1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Biorbyt Anti-SCD1 Antibody Product Portfolio
6.5.5 Biorbyt Recent Developments/Updates
6.6 Santa Cruz Biotechnology
6.6.1 Santa Cruz Biotechnology Company Information
6.6.2 Santa Cruz Biotechnology Description and Business Overview
6.6.3 Santa Cruz Biotechnology Anti-SCD1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Santa Cruz Biotechnology Anti-SCD1 Antibody Product Portfolio
6.6.5 Santa Cruz Biotechnology Recent Developments/Updates
6.7 LSBio
6.7.1 LSBio Company Information
6.7.2 LSBio Description and Business Overview
6.7.3 LSBio Anti-SCD1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 LSBio Anti-SCD1 Antibody Product Portfolio
6.7.5 LSBio Recent Developments/Updates
6.8 OriGene Technologies
6.8.1 OriGene Technologies Company Information
6.8.2 OriGene Technologies Description and Business Overview
6.8.3 OriGene Technologies Anti-SCD1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 OriGene Technologies Anti-SCD1 Antibody Product Portfolio
6.8.5 OriGene Technologies Recent Developments/Updates
6.9 Thermo Fisher Scientific
6.9.1 Thermo Fisher Scientific Company Information
6.9.2 Thermo Fisher Scientific Description and Business Overview
6.9.3 Thermo Fisher Scientific Anti-SCD1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Thermo Fisher Scientific Anti-SCD1 Antibody Product Portfolio
6.9.5 Thermo Fisher Scientific Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-SCD1 Antibody Industry Chain Analysis
7.2 Anti-SCD1 Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-SCD1 Antibody Production Mode & Process Analysis
7.4 Anti-SCD1 Antibody Sales and Marketing
7.4.1 Anti-SCD1 Antibody Sales Channels
7.4.2 Anti-SCD1 Antibody Distributors
7.5 Anti-SCD1 Antibody Customer Analysis
8 Anti-SCD1 Antibody Market Dynamics
8.1 Anti-SCD1 Antibody Industry Trends
8.2 Anti-SCD1 Antibody Market Drivers
8.3 Anti-SCD1 Antibody Market Challenges
8.4 Anti-SCD1 Antibody Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Anti-SCD1 Antibody Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Anti-SCD1 Antibody Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Anti-SCD1 Antibody Market Competitive Situation by Manufacturers in 2025
Table 4. Global Anti-SCD1 Antibody Sales (kg) of Key Manufacturers (2021–2026)
Table 5. Global Anti-SCD1 Antibody Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Anti-SCD1 Antibody Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Anti-SCD1 Antibody Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Anti-SCD1 Antibody Average Price (US$/g) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Anti-SCD1 Antibody, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Anti-SCD1 Antibody, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Anti-SCD1 Antibody, Product Types and Applications
Table 12. Global Key Manufacturers of Anti-SCD1 Antibody, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-SCD1 Antibody Companies by Tier (Tier 1, Tier 2, Tier 3), based on Anti-SCD1 Antibody Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-SCD1 Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Anti-SCD1 Antibody Sales by Region (kg), 2021–2026
Table 18. Global Anti-SCD1 Antibody Sales Market Share by Region (2021–2026)
Table 19. Global Anti-SCD1 Antibody Sales by Region (kg), 2027–2032
Table 20. Global Anti-SCD1 Antibody Sales Market Share by Region (2027–2032)
Table 21. Global Anti-SCD1 Antibody Revenue by Region (US$ Million), 2021–2026
Table 22. Global Anti-SCD1 Antibody Revenue Market Share by Region (2021–2026)
Table 23. Global Anti-SCD1 Antibody Revenue by Region (US$ Million), 2027–2032
Table 24. Global Anti-SCD1 Antibody Revenue Market Share by Region (2027–2032)
Table 25. North America Anti-SCD1 Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Anti-SCD1 Antibody Sales by Country (kg), 2021–2026
Table 27. North America Anti-SCD1 Antibody Sales by Country (kg), 2027–2032
Table 28. North America Anti-SCD1 Antibody Revenue by Country (US$ Million), 2021–2026
Table 29. North America Anti-SCD1 Antibody Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Anti-SCD1 Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Anti-SCD1 Antibody Sales by Country (kg), 2021–2026
Table 32. Europe Anti-SCD1 Antibody Sales by Country (kg), 2027–2032
Table 33. Europe Anti-SCD1 Antibody Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Anti-SCD1 Antibody Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Anti-SCD1 Antibody Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Anti-SCD1 Antibody Sales by Region (kg), 2021–2026
Table 37. Asia Pacific Anti-SCD1 Antibody Sales by Region (kg), 2027–2032
Table 38. Asia Pacific Anti-SCD1 Antibody Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Anti-SCD1 Antibody Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Anti-SCD1 Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Anti-SCD1 Antibody Sales by Country (kg), 2021–2026
Table 42. Latin America Anti-SCD1 Antibody Sales by Country (kg), 2027–2032
Table 43. Latin America Anti-SCD1 Antibody Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Anti-SCD1 Antibody Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Anti-SCD1 Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Anti-SCD1 Antibody Sales by Country (kg), 2021–2026
Table 47. Middle East and Africa Anti-SCD1 Antibody Sales by Country (kg), 2027–2032
Table 48. Middle East and Africa Anti-SCD1 Antibody Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Anti-SCD1 Antibody Revenue by Country (US$ Million), 2027–2032
Table 50. Global Anti-SCD1 Antibody Sales (kg) by Type (2021–2026)
Table 51. Global Anti-SCD1 Antibody Sales (kg) by Type (2027–2032)
Table 52. Global Anti-SCD1 Antibody Sales Market Share by Type (2021–2026)
Table 53. Global Anti-SCD1 Antibody Sales Market Share by Type (2027–2032)
Table 54. Global Anti-SCD1 Antibody Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Anti-SCD1 Antibody Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Anti-SCD1 Antibody Revenue Market Share by Type (2021–2026)
Table 57. Global Anti-SCD1 Antibody Revenue Market Share by Type (2027–2032)
Table 58. Global Anti-SCD1 Antibody Price (US$/g) by Type (2021–2026)
Table 59. Global Anti-SCD1 Antibody Price (US$/g) by Type (2027–2032)
Table 60. Global Anti-SCD1 Antibody Sales (kg) by Application (2021–2026)
Table 61. Global Anti-SCD1 Antibody Sales (kg) by Application (2027–2032)
Table 62. Global Anti-SCD1 Antibody Sales Market Share by Application (2021–2026)
Table 63. Global Anti-SCD1 Antibody Sales Market Share by Application (2027–2032)
Table 64. Global Anti-SCD1 Antibody Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Anti-SCD1 Antibody Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Anti-SCD1 Antibody Revenue Market Share by Application (2021–2026)
Table 67. Global Anti-SCD1 Antibody Revenue Market Share by Application (2027–2032)
Table 68. Global Anti-SCD1 Antibody Price (US$/g) by Application (2021–2026)
Table 69. Global Anti-SCD1 Antibody Price (US$/g) by Application (2027–2032)
Table 70. Abcam Company Information
Table 71. Abcam Description and Business Overview
Table 72. Abcam Anti-SCD1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 73. Abcam Anti-SCD1 Antibody Product
Table 74. Abcam Recent Developments/Updates
Table 75. Bioss Company Information
Table 76. Bioss Description and Business Overview
Table 77. Bioss Anti-SCD1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 78. Bioss Anti-SCD1 Antibody Product
Table 79. Bioss Recent Developments/Updates
Table 80. Bethyl Laboratories Company Information
Table 81. Bethyl Laboratories Description and Business Overview
Table 82. Bethyl Laboratories Anti-SCD1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 83. Bethyl Laboratories Anti-SCD1 Antibody Product
Table 84. Bethyl Laboratories Recent Developments/Updates
Table 85. HUABIO Company Information
Table 86. HUABIO Description and Business Overview
Table 87. HUABIO Anti-SCD1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 88. HUABIO Anti-SCD1 Antibody Product
Table 89. HUABIO Recent Developments/Updates
Table 90. Biorbyt Company Information
Table 91. Biorbyt Description and Business Overview
Table 92. Biorbyt Anti-SCD1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 93. Biorbyt Anti-SCD1 Antibody Product
Table 94. Biorbyt Recent Developments/Updates
Table 95. Santa Cruz Biotechnology Company Information
Table 96. Santa Cruz Biotechnology Description and Business Overview
Table 97. Santa Cruz Biotechnology Anti-SCD1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 98. Santa Cruz Biotechnology Anti-SCD1 Antibody Product
Table 99. Santa Cruz Biotechnology Recent Developments/Updates
Table 100. LSBio Company Information
Table 101. LSBio Description and Business Overview
Table 102. LSBio Anti-SCD1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 103. LSBio Anti-SCD1 Antibody Product
Table 104. LSBio Recent Developments/Updates
Table 105. OriGene Technologies Company Information
Table 106. OriGene Technologies Description and Business Overview
Table 107. OriGene Technologies Anti-SCD1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 108. OriGene Technologies Anti-SCD1 Antibody Product
Table 109. OriGene Technologies Recent Developments/Updates
Table 110. Thermo Fisher Scientific Company Information
Table 111. Thermo Fisher Scientific Description and Business Overview
Table 112. Thermo Fisher Scientific Anti-SCD1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 113. Thermo Fisher Scientific Anti-SCD1 Antibody Product
Table 114. Thermo Fisher Scientific Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Anti-SCD1 Antibody Distributors List
Table 118. Anti-SCD1 Antibody Customers List
Table 119. Anti-SCD1 Antibody Market Trends
Table 120. Anti-SCD1 Antibody Market Drivers
Table 121. Anti-SCD1 Antibody Market Challenges
Table 122. Anti-SCD1 Antibody Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anti-SCD1 Antibody
Figure 2. Global Anti-SCD1 Antibody Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Anti-SCD1 Antibody Market Share by Type: 2025 & 2032
Figure 4. Monoclonal Anti-SCD1 Antibody Product Picture
Figure 5. Polyclonal Anti-SCD1 Antibody Product Picture
Figure 6. Global Anti-SCD1 Antibody Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Anti-SCD1 Antibody Market Share by Application: 2025 & 2032
Figure 8. Co-Immunoprecipitation
Figure 9. Western Blot
Figure 10. Immunofluorescence
Figure 11. Others
Figure 12. Global Anti-SCD1 Antibody Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Anti-SCD1 Antibody Market Size (US$ Million), 2021–2032
Figure 14. Global Anti-SCD1 Antibody Sales (kg), 2021–2032
Figure 15. Global Anti-SCD1 Antibody Average Price (US$/g), 2021–2032
Figure 16. Anti-SCD1 Antibody Report Years Considered
Figure 17. Anti-SCD1 Antibody Sales Share by Manufacturers in 2025
Figure 18. Global Anti-SCD1 Antibody Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Anti-SCD1 Antibody Players: Market Share by Revenue in Anti-SCD1 Antibody in 2025
Figure 20. Anti-SCD1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Anti-SCD1 Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Anti-SCD1 Antibody Sales Market Share by Country (2021–2032)
Figure 23. North America Anti-SCD1 Antibody Revenue Market Share by Country (2021–2032)
Figure 24. United States Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Anti-SCD1 Antibody Sales Market Share by Country (2021–2032)
Figure 27. Europe Anti-SCD1 Antibody Revenue Market Share by Country (2021–2032)
Figure 28. Germany Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Anti-SCD1 Antibody Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Anti-SCD1 Antibody Revenue Market Share by Region (2021–2032)
Figure 35. China Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Anti-SCD1 Antibody Sales Market Share by Country (2021–2032)
Figure 43. Latin America Anti-SCD1 Antibody Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Anti-SCD1 Antibody Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Anti-SCD1 Antibody Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Anti-SCD1 Antibody by Type (2021–2032)
Figure 54. Global Revenue Market Share of Anti-SCD1 Antibody by Type (2021–2032)
Figure 55. Global Anti-SCD1 Antibody Price (US$/g) by Type (2021–2032)
Figure 56. Global Sales Market Share of Anti-SCD1 Antibody by Application (2021–2032)
Figure 57. Global Revenue Market Share of Anti-SCD1 Antibody by Application (2021–2032)
Figure 58. Global Anti-SCD1 Antibody Price (US$/g) by Application (2021–2032)
Figure 59. Anti-SCD1 Antibody Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
